More than 2,000 laid off at Johns Hopkins University amid Trump budget cuts

Johns Hopkins University announced Thursday it's laying off over 2,000 employees amid budget cuts made by the Trump administration.

The largest layoff in the school's history, 2,200 people will be laid off, and then another 100 will be subject to reduced schedules.

A spokesman for Johns Hopkins told USA Today that affected workers will get at least 60 days notice before being terminated, and that a large portion of those being let go are working abroad as the university specialized in research projects funded by USAID, which has been drastically cut by Trump.

The university had been receiving the largest amount of federal research financing of all American universities and is still the largest employer in the state of Maryland.

Read Full Article Here
 

Follow us

Read our latest news on any of these social networks!

Get latest news delivered daily!

We will send you breaking news right to your inbox


Have a tip? Let us know!

Recent Articles

  • by:
  • Source: AP News
  • 03/14/2025
...
Trump administration asks Supreme Court to partly allow birthright citizenship restrictions

The Trump administration is asking the Supreme Court to allow restrictions on birthright citizenship to partly take effect while legal fights play out.

  • by:
  • Source: Fox News
  • 03/14/2025
...
Chuck Schumer will vote to keep government open: 'For Donald Trump, a shutdown would be a gift'

Senate Minority Leader Chuck Schumer, D-N.Y., says he will vote to keep the government open, warning that a shutdown has worse consequences for Americans and would only empower President Donald Trump and Elon Musk further.

...
ICE: US Immigration Detention Maxed at 47.6K Detainees

U.S. immigration detention is filled to capacity at 47,600 detainees, a senior U.S. Immigration and Customs Enforcement official said on a call with reporters on Wednesday, adding that the Trump administration was seeking more bed space.

...
Yearly HIV prevention injection 'Lenacapavir' shows promise in clinical trial

Pain at the injection site was the most common adverse event, which was generally mild, resolved within one week.